Control of metabolism with human 2-oxoglutarate carrier

Details Control of metabolism with human 2-oxoglutarate carrier Control of metabolism with human 2-oxoglutarate carrier

2006-11-28

2006-11-28

Falk, Anne-Marie (Department: 1635)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of regulating cell metabolism or physiology

C435S003000, C435S004000, C435S006120, C435S007100

Reexamination Certificate

active

07141421

ABSTRACT:
The present invention is directed to compositions and methods related to the use of human OGC as an uncoupling protein.

REFERENCES:
patent: 5364934 (1994-11-01), Drayna et al.
patent: 6132973 (2000-10-01), Lal et al.
patent: WO 99/00123 (1999-01-01), None
patent: WO 99/00123 (1999-01-01), None
patent: WO 99/64458 (1999-12-01), None
patent: WO 99/64458 (1999-12-01), None
patent: WO 00/04037 (2000-01-01), None
patent: WO 00/61614 (2000-10-01), None
patent: WO 01/98355 (2001-12-01), None
patent: WO 01/98512 (2001-12-01), None
Appleby, R.D. et al. Quantitation and origin of the mitochondrial membrane potential in human cells lacking mitochondrial DNA (Eur. J. Biochem. vol. 262, p. 108-116; May 1999).
Guo et al. American Journal of Physiology, 1999, pp. L1018-L1026.
Daniel et al. Neurogastroenterol. Mot., 2001, pp. 297-307.
A Palmisano et al., J. Biochem.,“Targeting and assembly of the oxoglutarate carrier: general principles for biogenesis of carrier proteins of the mitochondrial inner membrane,” 1998, 333, pp. 151-158.
Xing Xian Yu, et al., 2001. Overexpression of the human 2-oxoglutarate carrier lowers mitochondrial membrane potential in HEK-293 cells: contrast with the unique cold-induced mitochondrial carrier CGI-69,Biochem. J.,353:369-375.
Zhang, Chen-Yu, et al., 1999. Assessment of uncoupling activity of uncoupling protein 3 using a yeast heterologous expression system,Fed. Of Euro. Biochem. Soc.,449:129-134.
DAS, Kallol, et al., 1999. Predominant expression of the mitochondrial dicarboxylate carrier in white adipose tissue,Biochem J.,344:313-320.
Walker, John E. and M.J. Runswick, 1993. The Mitochondrial Transport Protein Superfamily,J. of Bioenergetics and Biomembranes, 25:435-446.
Jezek, Petr, et al., 1998. Fatty acid cycling mechanism and mitochondrial uncoupling proteins,Biochimica et Biophysica Acta.,1365:319-327.
Anderson, B., et al., Genbank Accession AF070548. Aug. 1998.
Tisdale, M., “Cancer Cachexia: Metabolic Alterations and Clinical Manifestations,”Nutrition, 13:1-7 (1997) (complete reference herewith submitted).
Adams, S., “Uncoupling Protein Homologs: Emerging Views of Physiological Function,”J. Nutr.130:711-714 (2000).
Boss, O., S. Samec, A. Paoloni-Giacobino, C. Rossier, et al., “Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression,”FEBS Letters, 408:39-42 (1997).
Bouillaud, F., D. Ricquier, J. Thibault, and J. Weissenbach, “Molecular Approach to Thermogenesis in Brown Adipose Tissue: cDNA Cloning of the Mitochondrial Uncoupling Protein,”Proc. Natl. Acad. Sci.,82(2):445-448 (1985).
Brand, M., L. Chien, E. Ainscow, D. Rolfe, et al., “The causes and functions of mitochondrial proton leak,”Biochim. Biophys. Acta.,1187:132-139 (1994).
Bray, G., “Progress in Understanding the Genetics of Obesity.”J Nutr.,127:940S-942S (1997).
Carter, P., H. Bedouelle, and G. Winter, “Improved oligonucleotide site-directed mutagenesis using M13 vectors,”Nucl. Acids Res.,13:4431-4443 (1985).
Cassard, A., F. Bouillaud, M. Mattei, E. Hentz, et al., “Human Uncoupling Protein Gene: Structure, Comparison With Rat Gene, and Assignment to the Long Arm of Chromosome 4,”J. Cell Biochem.,43:255-264 (1990).
Chothia, C., “The Nature of the Accessible and Buried Surfaces in Proteins,”J. Mol. Biol.,105:1-14 (1976).
Creighton, “Posttranslational Covalent Modifications of Polypeptide Chains,”in“Proteins: Structure and Molecular Properties,” (W.H., Freeman & Co.) (San Fran., CA), pp. 78-86 (1983).
Cunningham, B. and J. Wells, “High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis,”Science, 244:1081-1085 (1989).
Fleury, C., M. Neverova, S. Collins, S. Raimbault, et al., “Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia,”Nat. Genet.,15:269-272 (1997).
Gimeno, R., M. Dembski, X. Weng, N. Deng, et al., “Cloning and Characterization of an Uncoupling Protein Homolog. A Potential Molecular Mediator of Human Thermogenesis,”Diabetes, 46:900-906 (1997).
Goldstein, S. and D. Elwyn, “The effects of injury and sepsis on fuel utilization,”Annu. Rev. Nutr.,9:445-473 (1989).
Gong, D., Y. He, M. Karas, and M. Reitman, “Uncoupling Protein-3 Is a Mediator of Thermogenesis Regulated by Thyroid Hormone, β3-Adrenergic Agonists, and Leptin,”J. Biol. Chem.,272(39):24129-24132 (1997).
Gura, T., “Uncoupling Proteins Provide New Clue to Obesity's Causes,”Science, 280:1369-1370 (1998).
Hill, J. and J. Peters, “Environmental Contributions to the Obesity Epidemic,”Science, 280:1371-1374 (1998).
Iacobazzi, V., et al. GenBank Accession No. NM—003562 (1992).
Iacodazzi, V., F. Palmieri, M. Runswick, and J. Walker, “Sequences of the human and bovine genes for the mitochondrial 2-oxoglutarate carrier,”DNA Seq.,3(2):79-88 (1992).
Jacobsson, A., U. Stadler, M. Glotzer, and L. Kozak, “Mitochondrial Uncoupling Protein from Mouse Brown Fat,”J. Biol. Chem.,260(30):16250-16254 (1985).
Je{hacek over (z)}ek, P., H. Engstova, M. Zackova, A. Vercesi, et al., “Fatty acid cycling mechanism and mitochondrial uncoupling proteins,”Biochim. Biophys. Acta.,1365:319-327 (1998).
Kallol, D., R. Lewis, T. Combatsiaris, Y. Lin, et al., “Predominant expression of the mitochondrial dicarboxylate carrier in white adipose tissue,”Biochem. J.,344:313-320 (1999).
Kinney, J., J. Duke, Jr., C. Long, and F. Gump, “Tissue fuel and weight loss after injury.”J. Clin. Path.,23(4):65-72 (1970).
Lai, C., C. Chou, L. Ch'ang, C. Liu, and C. Liu, et al., GenBank Accession No. AF151827 (2000).
Lai, C., C. Chou, L. Ch'ang, C. Liu, and W. Lin, “Identification of Novel Human Genes Evolutionarily Conserved inCaenorhabditis elegansby Comparative Proteomics,”Genome Res.,10:703-713 (2000).
Mao, W., X. Yu, A. Zhong, W. Li, et al. “UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells,”FEBS Lett.443:326-330 (1999).
Must, A., J. Spadano, E. Coakley, A.E. Field, et al. “The Disease Burden Associated With Overweight And Obesity.”JAMA.,282:1523-1529 (1999).
Nicholls, D. and R. Locke, “Thermogenic Mechanisms in Brown Fat,”Physiol. Rev.,64:1-64 (1984).
Palmieri, F., F. Bisaccia, L. Capobianco, V. Dolce, et al., “Transmembrane Topology, Genes, and Biogenesis of the Mitochondrial Phosphate and Oxoglutarate Carriers,”J. Bioenerg. Biomemb.,25(5)493-501 (1993).
Palmisano, A., V. Zara, A. Hönlinger, A. Vozza, et al., “Targeting and assembly of the oxoglutarate carrier: general principles for biogenesis of carrier proteins of the mitochondrial inner membrane,”Biochem J.333:151-158 (1998).
Piccininni, S., V. Iacobazzi, G. Lauria, M. Rocchi, and F. Palmieri, “Assignment of the oxoglutarate carrier gene (SLC20A4) to human chromosome 17p13.3,”Cytogenet. Cell Genet.,83:256-257 (1998).
Poutska, A., M. Klein, H. Mewes, J. Gassenhuber, and S. Wiemann, GenBank Accession No. AL133584 (1999).
Ricquier, D., L. Casteilla, and F. Bouillaud, “Molecular studies of the uncoupling protein,”FASEB J,.5:2237-2242 (1991).
Rolfe, D., A. Hulbert, and M. Brand, “Characteristics of mitochondrial proton leak and control of oxidative phosphorylation in the major oxygen-consuming tissues of the rat,”Bicohim. Biophys. Acta.,1118:405-416 (1994).
Rolfe, D., J. Newman, J. Buckingham, M. Clark, et al. “Contribution of mitochondrial proton leak to respiration rate in working skeletal muscle and liver and to SMR,”Am. J. Physiol.,276:C692-C699 (1999).
Runswick, M., J. Walker, F. Bisaccia, V. Iacobazzi, and F. Palmieri, GenBank Accession No. AAA30672 (1990).
Sanchis, D., C. Fleury, N. Chomiki, M. Goubern, et al., “BMCP1, a Novel Mitochondrial Carrier with High Expression in the

Affiliated with

Also associated with

Rating

Control of metabolism with human 2-oxoglutarate carrier does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Control of metabolism with human 2-oxoglutarate carrier, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Control of metabolism with human 2-oxoglutarate carrier will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3649581